E9-25894. Manufacturer of Controlled Substances; Notice of Registration  

  • Start Preamble

    By Notice dated June 22, 2009, and published in the Federal Register on June 30, 2009, (74 FR 31314), Chattem Chemicals Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:

    DrugSchedule
    4-Methoxyamphetamine (7411)I
    Dihydromorphine (9145)I
    Amphetamine (1100)II
    Methamphetamine (1105)II
    Lisdexamfetamine (1205)II
    Methylphenidate (1724)II
    Pentobarbital (2270)II
    Codeine (9050)II
    Dihydrocodeine (9120)II
    Oxycodone (9143)II
    Hydromorphone (9150)II
    Hydrocodone (9193)II
    Meperidine (9230)II
    Morphine (9300)II
    Oripavine (9330)II
    Thebaine (9333)II
    Oxymorphone (9652)II
    Noroxymorphone (9668)II
    Alfentanil (9737)II
    Remifentanil (9739)II
    Sufentanil (9740)II
    Fentanyl (9801)II

    The company plans to manufacture the listed controlled substances in bulk for distribution to its customers.

    No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Chattem Chemicals Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Chattem Chemicals Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the Start Printed Page 55591company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

    Start Signature

    Dated: October 20, 2009.

    Joseph T. Rannazzisi,

    Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

    End Signature End Preamble

    [FR Doc. E9-25894 Filed 10-27-09; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
10/28/2009
Department:
Drug Enforcement Administration
Entry Type:
Notice
Document Number:
E9-25894
Pages:
55590-55591 (2 pages)
PDF File:
e9-25894.pdf